Literature DB >> 12027742

Tricalysiosides A-G: rearranged ent-kauranoid glycosides from the leaves of Tricalysia dubia.

Dong-Hui He1, Hideaki Otsuka, Eiji Hirata, Takakazu Shinzato, Masahiko Bando, Yoshio Takeda.   

Abstract

Seven rearranged ent-kaurane glycosides, named tricalysiosides A-G (1-7), were isolated from the leaves of Tricalysia dubia collected on Okinawa Island. Their C-18 and 19 methyls were found to have rearranged to form an alpha,beta-unsaturated gamma-lactone ring, with other functional groups remotely located only on C-15, -16, and -17 of the five-membered ring. Information available from various kinds of two-dimensional NMR spectra was limited and insufficient to allow total characterization of the structures. Finally, using X-ray crystallographic analysis, the structure of tricalysioside A (1) was determined to be 4-nor-18-homo-ent-kauran-4(18)-en-15beta,16beta,17-triol-3beta,19-olide 16-O-beta-D-glucopyranoside (1). On the basis of the crystal structure of 1, the structures of the other tricalysiosides (2-7) were also established.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027742     DOI: 10.1021/np010620t

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  ent-Kaurane glycosides from Tricalysia okelensis.

Authors:  Wen-Hui Xu; Melissa Ruth Jacob; Ameeta Kishore Agarwal; Alice Mae Clark; Zong-Suo Liang; Xing-Cong Li
Journal:  Chem Pharm Bull (Tokyo)       Date:  2010-02       Impact factor: 1.645

Review 2.  Occurrence, biological activities and synthesis of kaurane diterpenes and their glycosides.

Authors:  Pablo Anselmo García; Alaíde Braga de Oliveira; Ronan Batista
Journal:  Molecules       Date:  2007-03-13       Impact factor: 4.411

3.  Rearranged ent-kauranes from the stems of Tricalysia dubia and their biological activities.

Authors:  Naoko Tamaki; Katsuyoshi Matsunami; Hideaki Otsuka; Takakazu Shinzato; Mitsunori Aramoto; Yoshio Takeda
Journal:  J Nat Med       Date:  2008-04-15       Impact factor: 2.343

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.